nucleotidylexotransferase
terminal deoxynucleotidyl transferase
mogamulizumab
hybridoma
antirecombination
lymphogenously
chromatoid
IGHV
immunoblast
lymphoblast
excinuclease
lymphocytic leukemia
chromomycosis
Pedroso's disease
cladosporiosis
phaeosporotrichosis
Fonseca's disease
lymphogenically
acute lymphoblastic leukemia
chromidium
memory cell
chromatoblast
plasma cell
lymphomagenic
gene gun
deoxynucleotidyltransferase
plasmacyte
adecatumumab
lenzilumab
recombinogenic
transchromosomic
exonucleotide
acute lymphocytic leukemia
idiochromatin
alymphocytosis
hematogone
galiximab
bivatuzumab
chromomere
sonepcizumab
pamrevlumab
antinucleoprotein
elotuzumab
sister chromatid
lymphoplasmocytic
recombinative
tucotuzumab
heterochromosome
immunochromogenic
interchromatin
interchromatic
lymphocytotic
decondensing
chromomeric
nucleocytoplasmically
antinucleotide
alloreactivity
lymphoplasmacellular
oleclumab
Waldenström's macroglobulinemia
antinucleosome
recombining
chromatinized
lymphocytotropic
immunocytometry
intralymphocytic
immunocytoma
lymphoblastic leukemia
germinal center
centroblast
antibody
lymphopoiesis
chromism
talacotuzumab
nucleofection
lymphomagenesis
recombinant
lymphomononuclear
paraimmunoblast
guselkumab
antilymphangiogenic
rDNA
CD22
heterochromosomal
immunoglobulin D
patritumab
onartuzumab
nucleocytoplasmic
antirecombinogenic
prolymphangiogenic
alemtuzumab
dimerizer
glembatumumab
poly(C)
recombine
intetumumab
core histone